Evidence map›Paper›PMID 28575647›Full record

ArticleAmerican journal of human genetics2017

YY1 Haploinsufficiency Causes an Intellectual Disability Syndrome Featuring Transcriptional and Chromatin Dysfunction.

Michele Gabriele, Anneke T Vulto-van Silfhout, Pierre-Luc Germain, Alessandro Vitriolo, Raman Kumar, Evelyn Douglas, Eric Haan, Kenjiro Kosaki, Toshiki Takenouchi, Anita Rauch and 41 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 2 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 2 syntheses or guidelines pooled it, 165 citations in OpenAlex.

  1. BCL11B-related disease: a single phenotypic entity?European journal of human genetics : EJHG · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Loss of function of the chromatin remodeling geneProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Article
  11. Defective Astrocyte Maturation Drives Cerebellar Neuroinflammation and Degeneration.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  12. De novo variants in RYBP are associated with a severe neurodevelopmental disorder and congenital anomalies.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  13. Yin Yang 1: Function, Mechanisms, and Glia.Neurochemical research · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

51 authors at 20 institutions in 11 countries.

Michele GabrieleLaboratory of Stem Cell Epigenetics, Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy.
Anneke T Vulto-van SilfhoutDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Pierre-Luc GermainLaboratory of Stem Cell Epigenetics, Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy.
Alessandro VitrioloLaboratory of Stem Cell Epigenetics, Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy.
Raman KumarSchool of Medicine and Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia.
Evelyn DouglasSA Clinical Genetics Service, SA Pathology, Adelaide, SA 5000, Australia; School of Medicine, University of Adelaide, Adelaide, SA 5000, Australia.
Eric HaanSA Clinical Genetics Service, SA Pathology, Adelaide, SA 5000, Australia; School of Medicine, University of Adelaide, Adelaide, SA 5000, Australia.
Kenjiro KosakiCenter for Medical Genetics, Keio University School of Medicine, 160-8582 Tokyo, Japan.
Toshiki TakenouchiCenter for Medical Genetics, Keio University School of Medicine, 160-8582 Tokyo, Japan.
Anita RauchInstitute of Medical Genetics, University of Zurich, 8952 Schlieren-Zurich, Switzerland.
Katharina SteindlInstitute of Medical Genetics, University of Zurich, 8952 Schlieren-Zurich, Switzerland.
Eirik FrengenDepartment of Medical Genetics, University of Oslo and Oslo University Hospital, 0315 Oslo, Norway.
Doriana MisceoDepartment of Medical Genetics, University of Oslo and Oslo University Hospital, 0315 Oslo, Norway.
Christeen Ramane J PedurupillayDepartment of Medical Genetics, University of Oslo and Oslo University Hospital, 0315 Oslo, Norway.
Petter StrommeDivision of Paediatric and Adolescent Medicine, Oslo University Hospital and University of Oslo, 0313 Oslo, Norway.
Jill A RosenfeldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Yunru ShaoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
William J CraigenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Christian P SchaafDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
David Rodriguez-BuriticaDivision of Genetics, Department of Pediatrics, University of Texas Health, Houston, TX 77030, USA.
Laura FarachDivision of Genetics, Department of Pediatrics, University of Texas Health, Houston, TX 77030, USA.
Jennifer FriedmanDepartments of Neurosciences and Pediatrics, University of California, San Diego, and Rady Children's Hospital, San Diego, CA 92123, USA.
Perla ThulinDepartment of Neurology, University of Utah, San Diego, CA 92123, USA.
Scott D McLeanClinical Genetics Section, Children's Hospital of San Antonio, San Antonio, TX 78207, USA.
Kimberly M NugentClinical Genetics Section, Children's Hospital of San Antonio, San Antonio, TX 78207, USA.
Jenny MortonBirmingham Women's Hospital, B15 2TG Birmingham, UK.
Jillian NichollSA Clinical Genetics Service, SA Pathology, Adelaide, SA 5000, Australia; School of Medicine, University of Adelaide, Adelaide, SA 5000, Australia.
Joris AndrieuxInstitut de Génétique Médicale, Hopital Jeanne de Flandre, 59000 Lille, France.
Asbjørg Stray-PedersenHuman and Medical Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Pascal ChambonLaboratory of Cytogenetics, Rouen University Hospital, 76031 Rouen, France.
Sophie PatrierService d'Anatomie Pathologique, Rouen University Hospital, 76031 Rouen, France.
Sally A LynchNational Centre for Medical Genetics, Our Lady's Children's Hospital, D12 V004 Dublin, Ireland.
Susanne KjaergaardDepartment of Clinical Genetics, Rigshospitalet, 2100 Copenhagen, Denmark.
Pernille M TørringDepartment of Clinical Genetics, Odense University Hospital, 5000 Odense, Denmark.
Charlotte Brasch-AndersenDepartment of Clinical Genetics, Odense University Hospital, 5000 Odense, Denmark.
Anne RonanHunter Genetics, Waratah, NSW 2298, Australia.
Arie van HaeringenDepartment of Clinical Genetics, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
Peter J AndersonAustralian Craniofacial Unit, Women's and Children's Hospital, North Adelaide, SA 5006, Australia.
Zöe PowisAmbry Genetics, Aliso Viejo, CA 92656, USA.
Han G BrunnerDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Rolph PfundtDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Janneke H M Schuurs-HoeijmakersDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Bregje W M van BonDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Stefan LelieveldDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Christian GilissenDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Willy M NillesenDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Lisenka E L M VissersDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Jozef GeczSchool of Medicine and Robinson Research Institute, University of Adelaide, Adelaide, SA 5000, Australia; South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.
David A KoolenDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Giuseppe TestaLaboratory of Stem Cell Epigenetics, Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy. Electronic address: giuseppe.testa@unimi.it.
Bert B A de VriesDepartment of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands. Electronic address: bert.devries@radboudumc.nl.
Radboud University Nijmegen · NLBaylor College of Medicine · USUniversity of Adelaide · AUEuropean Institute of Oncology · ITUniversity of Oslo · NOChildren's Hospital of San Antonio · USKeio University · JPOdense University Hospital · DKRadboud University Medical Center · NLThe University of Texas Health Science Center at Houston · USUniversité de Rouen Normandie · FRUniversity of Zurich · CHAmbry Genetics (United States) · USBirmingham Women's Hospital · GBHôpital Jeanne de Flandre · FRHunter Genetics · AULeiden University Medical Center · NLNational Children’s Research Centre · IEOslo University Hospital · NORady Children's Hospital-San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Yin and yang 1 (YY1) is a well-known zinc-finger transcription factor with crucial roles in normal development and malignancy. YY1 acts both as a repressor and as an activator of gene expression. We have identified 23 individuals with de novo mutations or deletions of YY1 and phenotypic features that define a syndrome of cognitive impairment, behavioral alterations, intrauterine growth restriction, feeding problems, and various congenital malformations. Our combined clinical and molecular data define "YY1 syndrome" as a haploinsufficiency syndrome. Through immunoprecipitation of YY1-bound chromatin from affected individuals' cells with antibodies recognizing both ends of the protein, we show that YY1 deletions and missense mutations lead to a global loss of YY1 binding with a preferential retention at high-occupancy sites. Finally, we uncover a widespread loss of H3K27 acetylation in particular on the YY1-bound enhancers, underscoring a crucial role for YY1 in enhancer regulation. Collectively, these results define a clinical syndrome caused by haploinsufficiency of YY1 through dysregulation of key transcriptional regulators.

Indexed as

Transcription, GeneticAcetylationAdolescentBase SequenceChild, PreschoolChromatinChromatin ImmunoprecipitationCohort StudiesEnhancer Elements, GeneticFemaleGene OntologyHaploinsufficiencyHaplotypesHemizygoteHistonesHumansChromatinHistonesYY1 Transcription FactorchromatinenhancerepigeneticsH3K27Achaploinsufficiencyintellectual disabilityneurodevelopmentsyndrometranscription factorYY1

Identifiers

PMID28575647
PMCPMC5473733
OpenAlexW2620797288

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.